Lin Yang

Lin Yang is an accomplished professional in bioanalytical research, currently serving as the Director Integrated Bioanalysis-Team Lead at AstraZeneca since April 2024. Prior to this role, Lin held multiple leadership positions at REGENXBIO Inc. from December 2017 to April 2024, culminating in the role of Senior Director of Bioanalytical Research. Lin's experience also includes serving as Associate Director of Method Development at Smithers Avanza for a brief period in late 2017 and a long tenure at Covance from July 2000 to November 2017, where roles ranged from Senior Manager of Method Development to Senior Principal Investigator. Lin Yang holds a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from East Tennessee State University, alongside a Bachelor's Degree and a Master's Degree in Chemistry from Wuhan University.